New drug combo trial offers hope for Tough-to-Treat uterine cancer
NCT ID NCT03008408
Summary
This study is testing whether adding a drug called ribociclib to a two-drug combination (everolimus and letrozole) works better for women with advanced or returning endometrial cancer. The trial will enroll 90 participants to see if the three-drug combo helps control the cancer longer and is safe. This is a Phase 2 study, meaning researchers are checking how well it works and monitoring side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ENDOMETRIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026-1967, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.